Contact this trialFirst, we need to learn more about you.
Chemotherapy
Eltanexor + Inqovi for Myelodysplastic Syndrome
Recruiting1 awardPhase 1 & 2
Bethesda, Maryland
This trial is testing a new drug combination (KPT-8602 and Inqovi) for adults with severe blood disease (high-risk MDS) who haven't improved with standard treatments. Inqovi stops cancer cell growth, while KPT-8602 blocks a protein that helps cancer cells survive.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service